Cancer Genomics & Proteomics (CGP) is an international online-only open access, peer reviewed bimonthly journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to experimental and clinical cancer research. CGP was established in 2004.
Impact factor (2021): 3.395
Total cites: 1,640
Special Issue on Emerging Technologies in Cancer Research
High-throughput genomic technologies continuously advance and offer new opportunities to better understand and treat cancer. The past decade has seen a plethora of next-generation sequencing and data analysis studies, allowing us to map the genomic landscapes of various cancer types, while single cell analyses are shedding light on tumor heterogeneity. Groundbreaking new technologies, such as spatial omics, can give us unprecedented insight into the spatiotemporal tumor architecture and micro-environment. In this regard, this special issue aims to bring together review articles, experimental and clinical studies on the following topics:
– Whole-genome sequencing
– Single-cell genomics
– Mutational signatures
– Spatial transcriptomics
– Tumor architecture
– Tumor progression
– Data analysis methods / bioinformatics /machine learning
– Tumor heterogeneity
– Circulating tumor cells
– Precision medicine
– Tumor microenvironment interactions
– Computational immunology
– New therapeutic targets
Publication date: December 1, 2023; Submission deadline: November 3, 2023.
Instructions for the preparation and submission of reviews and original articles.
Click here to see the contents
Contents of Current Issue
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389